Evidence map›Paper›PMID 30646560›Full record

ReviewInternational journal of molecular sciences2019

Protective Smell of Hydrogen Sulfide and Polysulfide in Cisplatin-Induced Nephrotoxicity.

Xu Cao, Wencan Zhang, Philip K Moore, Jinsong Bian

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. HFrontiers in chemistry · 2023
    Review
  9. Article
  10. Review
  11. Review
  12. HBiomolecules · 2021
    Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 2 countries.

Xu CaoDepartment of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117600, Singapore. xu_cao@u.nus.edu.ORCID 0000-0002-9927-6802
Wencan ZhangFood Science and Technology Program, Department of Chemistry, National University of Singapore, Singapore 117600, Singapore. a0134754@u.nus.edu.
Philip K MooreDepartment of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117600, Singapore. dprmpk@nus.edu.sg.
Jinsong BianDepartment of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117600, Singapore. phcbjs@nus.edu.sg.
National University of Singapore · SG

Funding

Ministry of Education of Singapore Tier 2 Research grant (MOE2017-T2-2-029)National Medical Research Council CIRG/1432/2015
6 · The paper itself

Abstract

Though historically known as a toxic gas, hydrogen sulfide (H₂S) has displayed a new face as the third endogenous gaseous signaling molecule after nitric oxide (NO) and carbon monoxide (CO). Here in this review, we survey the role and therapeutic potential of H₂S in cisplatin-induced nephrotoxicity. Specifically, reduction of H₂S by cystathionine γ-lyase (CSE) downregulation upon cisplatin treatment may contribute to cisplatin-induced renal cell injury, possibly by augmentation of endogenous reactive oxygen species (ROS) production, while H₂S donation may prevent subsequent renal dysfunction by inhibiting NADPH oxidase activation. Intriguingly, H₂S slow-releasing compound GYY4137 seems to increase the anticancer activity of cisplatin, at least in several cancer cell lines, and this is probably due to its own anticancer effect. However, the efficacy of H₂S donors in tumor-bearing animals remains to be tested in terms of renal protection and cancer inhibition after receiving cisplatin. Furthermore, accumulative evidence regarding usage of polysulfide, a novel H₂S derived molecule, in the therapy of cisplatin-induced nephrotoxicity, was also summarized.

Indexed as

CisplatinCystathionine gamma-LyaseGene Expression Regulation, NeoplasticHumansHydrogen SulfideKidneyKidney DiseasesMorpholinesNeoplasmsOrganothiophosphorus CompoundsOxidation-ReductionReactive Oxygen SpeciesSmellCisplatinCystathionine gamma-LyaseGYY 4137Hydrogen SulfideMorpholinesOrganothiophosphorus CompoundsReactive Oxygen Speciescisplatin-induced nephrotoxicitycystathionine γ-lyaseGYY4137hydrogen polysulfidehydrogen sulfideNADPH oxidase

Identifiers

PMID30646560
PMCPMC6359127
OpenAlexW2910652467

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.